Search for: "Doe v. Mylan Pharmaceuticals, Inc." Results 1 - 20 of 163
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Apr 2023, 5:18 am by Annsley Merelle Ward
The CA upheld this in Neurim v Generics UK Limited (t/a Mylan) [2022] EWCA Civ 370. [read post]
1 Oct 2022, 2:31 pm by Lawrence B. Ebert
The outcome: Mylan Pharmaceuticals Inc. [read post]
26 Sep 2022, 4:49 am by Dennis Crouch
Skinny Label Infringement in Teva Pharmaceuticals USA, Inc. v. [read post]
1 Feb 2022, 1:22 pm by Dennis Crouch
Mylan Pharmaceuticals Inc., Docket No. 21-01729 (Fed. [read post]
6 Nov 2020, 7:16 am by Dennis Crouch
” On the facts here: Mylan Pharmaceuticals Inc. [read post]
13 Sep 2019, 11:09 am by Dennis Crouch
Mylan Pharmaceuticals Inc., 896 F.3d 1332 (Fed. [read post]
24 Jun 2019, 10:00 pm
Mylan Pharmaceuticals, Inc., 896 F.3d 1322 (Fed. [read post]
16 Jun 2019, 9:30 pm by Patent Docs
Mylan Pharmaceuticals Inc.), held that State sovereign immunity does not preclude institution of inter partes review proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
14 May 2019, 11:24 am by Lawrence B. Ebert
Mylan Labs., Inc., 464 F.3d 1286,1289 (Fed. [read post]